As of today, the Collaborating Centres in the Region have been supporting the Organization with COVID-19 related initiatives on several topics.
Laboratory Biosafety and Quality
As a joint effort, the WHO Collaborating Centre (CC) on Laboratory Biosafety at the Instituto de Diagnóstico y Referencia Epidemiológicos (InDRE), Ministry of Health (MEX-31), the WHO CC on Laboratory Quality Management at the Instituto de Diagnóstico y Referencia Epidemiológicos (InDRE), Ministry of Health (MEX-34), and the WHO CC for Surveillance, Epidemiology & Control of Influenza at the Influenza Division, National Center for Immunization and Other Respiratory Diseases, Centers for Disease Control and Prevention (CDC) (USA-118) are conducting the following activities:
- Standard Operating Procedures (SOP)
- Quality Control/Quality Assurance
- Biosafety and Biosecurity
- Health Promotion and Risk Communication
- Periodic and situational reports
Rational Use of Medicines
In Argentina, the WHO CC on the Rational Use of Medicines at the Centro Universitario de Farmacología, Facultad de Ciencias Médicas, Universidad Nacional de la Plata (ARG-30) supported the development of the Essential Medicines List for Management of Patients admitted to Intensive Care Units with Suspected or Confirmed COVID-19 Diagnosis.
eHealth and Digital Health
As a joint effort, the WHO CC in Knowledge Management at the Departamento de Informática en Salud, Hospital Italiano de Buenos Aires (ARG-34), the WHO CC in eHealth at the Faculty of Health Sciences, Universitat Oberta de Catalunya (SPA-50), and the WHO CC for Information Systems for Health at the Center for Public Health Analytics, School of Information Sciences, University of Illinois (USA-450) are helping to create COVID-19 Factsheets and Podcasts.
In Argentina, the WHO CC for Research, Referential Diagnosis, Biological Production & Training in Chagas & Parasitic Diseases at the Instituto Nacional de Parasitología “Dr. Mario Fatala Chaben”, Administración Nacional de Laboratorios e Institutos de Salud “Dr Carlos Malbrán” (ANLIS) (ARG-14) is supporting ANLIS in the diagnosis of COVID-19.
In Brazil, the WHO CC for Education of Health Technicians at the Escola Politécnica de Saúde Joaquim Venancio (EPSJV), Fundação Oswaldo Cruz (FIOCRUZ) (BRA-59) launched Orientaciones para Cuidaores de Adultos Mayores en el marco de la Epidemia del Nuevo Coronavirus Covid-19.
In the United States, the WHO CC for Nursing Human Resources Development and Patient Safety at the School of Nursing and Health Studies, University of Miami (USA-349) contributed to a chapter titled Nursing in the time of COVID-19: Two advanced practice nurses on the front lines of the pandemic in Perspectives and Contributions of Nursing to the Promotion of Universal Health.
In Canada, the WHO CC on Evidence-Informed Policy at the McMaster Health Forum, McMaster University (CAN-72) co-led the COVID-19 Evidence Network to support Decision-making (COVID-END) and led the preparation of rapid-evidence profiles to support government decision-making on COVID-19 topics.
In the United States, the WHO CC on Nutrition Research for Health at the Division of Nutritional Sciences, Cornell University (USA-457*) (currently in the process of designation, was USA-425 from 2016-2020) submitted a manuscript and published a protocol in PROSPERO with WHO to inform guidelines on infant feeding and received an NIH award to develop a point-of-care antigen/antibody test on the FeverPhone platform, particularly for use in resource-limited settings and ports of entry.
In Brazil, the WHO CC for Health Equity Monitoring at the International Center for Equity in Health, Federal University of Pelotas (BRA-84) co-led a virtual seminar titled Epidemiology and Inequalities in Brazil: The EpiCOVID19 Study.
In the United States, the WHO CC for National and Global Health Law at the O’Neill Institute for National and Global Health Law, Georgetown University (USA-414) contributed to the launch of the COVID-19 Law Lab, a database of laws that countries have implemented in response to the pandemic.